Two new studies led by researchers at The Ohio State University Wexner Medical Center and College of Medicine have shown that serum vitamin D levels in African Americans are associated with diabetes risk.
Nov 11, 2022
0
42
SGLT-2 inhibitors, a type of diabetes medicine, decreased cardiovascular risk among adults with chronic kidney disease, according to late-breaking research presented today at the American Heart Association's Scientific Sessions ...
Nov 7, 2022
0
16
Maternal health may play an important role in helping prevent kidney disease, according to a Monash University study that found the risk of developing the disease in adult life is partially determined at birth.
Oct 13, 2022
0
32
Use of an older class of type 2 diabetes drugs called glitazones, also known as thiazolidinediones or TZDs for short, is linked to a 22% reduced risk of dementia, reveals a long term study published in the open access journal ...
Oct 11, 2022
0
44
Women with severe preeclampsia (severe high blood pressure) during pregnancy may be treated with extended-release nifedipine, a blood pressure-lowering medicine, daily during the labor and delivery process, according to new ...
Oct 3, 2022
0
5
High-dose folic acid is protective against congenital malformations if the mother is at particular risk of having a child with congenital malformations. Treatment with antiseizure medication in pregnancy is associated with ...
Sep 28, 2022
0
65
Women with a history of diabetes in pregnancy can still reduce their chances of developing type 2 diabetes by adopting a healthy lifestyle, such as eating healthy, stopping smoking, exercising regularly, and not being overweight, ...
Sep 21, 2022
0
21
A combination of seven healthy lifestyle habits including sleeping seven to nine hours daily, exercising regularly and having frequent social contact was associated with a lower risk of dementia in people with type 2 diabetes, ...
Sep 14, 2022
0
46
A genetic risk for heart disease is far less predictive of problems than actual lifestyle risk factors such as high blood pressure, high cholesterol and diabetes—even among younger adults.
Jul 26, 2022
0
30
Sodium–glucose cotransporter 2 (SGLT2) inhibitors, such as empagliflozin, dapagliflozin, canagliflozin and ertugliflozin, have been game changers in the treatment of type 2 diabetes, but their potential for closing the ...
Jul 25, 2022
0
28
